Varbo A - Search Results

1

Extreme nonfasting remnant cholesterol vs extreme LDL cholesterol as contributors to cardiovascular disease and all-cause mortality in 90000 individuals from the general population.

Varbo A, Freiberg JJ, Nordestgaard BG. Varbo A, et al. Clin Chem. 2015 Mar;61(3):533-43. doi: 10.1373/clinchem.2014.234146. Epub 2015 Jan 20. Clin Chem. 2015. PMID: 25605681

2

TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population.

Varbo A, Benn M, Tybjærg-Hansen A, Grande P, Nordestgaard BG. Varbo A, et al. Arterioscler Thromb Vasc Biol. 2011 Feb;31(2):451-7. doi: 10.1161/ATVBAHA.110.216333. Epub 2010 Nov 11. Arterioscler Thromb Vasc Biol. 2011. PMID: 21071687

3

Nonfasting triglycerides, cholesterol, and ischemic stroke in the general population.

Varbo A, Nordestgaard BG, Tybjaerg-Hansen A, Schnohr P, Jensen GB, Benn M. Varbo A, et al. Ann Neurol. 2011 Apr;69(4):628-34. doi: 10.1002/ana.22384. Epub 2011 Feb 18. Ann Neurol. 2011. PMID: 21337605

4

Remnant cholesterol as a causal risk factor for ischemic heart disease.

Varbo A, Benn M, Tybjærg-Hansen A, Jørgensen AB, Frikke-Schmidt R, Nordestgaard BG. Varbo A, et al. J Am Coll Cardiol. 2013 Jan 29;61(4):427-436. doi: 10.1016/j.jacc.2012.08.1026. Epub 2012 Dec 19. J Am Coll Cardiol. 2013. PMID: 23265341 Free article.

5

Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.

Varbo A, Benn M, Tybjærg-Hansen A, Nordestgaard BG. Varbo A, et al. Circulation. 2013 Sep 17;128(12):1298-309. doi: 10.1161/CIRCULATIONAHA.113.003008. Epub 2013 Aug 7. Circulation. 2013. PMID: 23926208

6

Response: Lipoprotein subclass profiling reveals pleiotropy in the genetic variants of lipid risk factors for coronary heart disease: a note on Mendelian randomization studies.

Varbo A, Benn M, Tybjærg-Hansen A, Jørgensen AB, Frikke-Schmidt R, Nordestgaard BG. Varbo A, et al. J Am Coll Cardiol. 2013 Nov 12;62(20):1908-9. doi: 10.1016/j.jacc.2013.08.1615. Epub 2013 Sep 18. J Am Coll Cardiol. 2013. PMID: 24055748 Free article. No abstract available.

7

Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment.

Varbo A, Benn M, Nordestgaard BG. Varbo A, et al. Pharmacol Ther. 2014 Mar;141(3):358-67. doi: 10.1016/j.pharmthera.2013.11.008. Epub 2013 Nov 26. Pharmacol Ther. 2014. PMID: 24287311 Review.

8

Low nonfasting triglycerides and reduced all-cause mortality: a mendelian randomization study.

Thomsen M, Varbo A, Tybjærg-Hansen A, Nordestgaard BG. Thomsen M, et al. Among authors: varbo a. Clin Chem. 2014 May;60(5):737-46. doi: 10.1373/clinchem.2013.219881. Epub 2014 Jan 16. Clin Chem. 2014. PMID: 24436475

9

Reply to letters regarding article, "Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation".

Varbo A, Benn M, Tybjærg-Hansen A, Nordestgaard BG. Varbo A, et al. Circulation. 2014 Jun 17;129(24):e656. doi: 10.1161/CIRCULATIONAHA.114.009348. Circulation. 2014. PMID: 24934470 No abstract available.

10

Remnant cholesterol and ischemic heart disease.

Varbo A, Nordestgaard BG. Varbo A, et al. Curr Opin Lipidol. 2014 Aug;25(4):266-73. doi: 10.1097/MOL.0000000000000093. Curr Opin Lipidol. 2014. PMID: 24977981 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters